Treatment of complex recurrent fistula-in-ano by surgery combined to autologous bone marrow–derived mesenchymal stroma cells and platelet-rich plasma injection

No abstract is available for this paper.

• Publication year

  2019

• Venue

  International Journal of Colorectal Disease

• Publication date

  2019-08-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00384-019-03367-2PMID 31455971
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunomodulatory effect of mesenchymal stem cells: Cell origin and cell quality variations

  2019cited by this paper
• Systematic review with meta‐analysis: Safety and efficacy of local injections of mesenchymal stem cells in perianal fistulas

  2019cited by this paper
• Use of platelet-rich plasma and platelet-derived patches to treat chronic wounds.

  2019cited by this paper
• Management of anoperineal lesions in Crohn’s disease: a French National Society of Coloproctology national consensus

  2018cited by this paper
• A Step-By-Step Surgical Protocol for the Treatment of Perianal Fistula with Adipose-Derived Mesenchymal Stem Cells

  2018cited by this paper
• A Systematic Review and Meta-analysis of Mesenchymal Stem Cell Injections for the Treatment of Perianal Crohn’s Disease: Progress Made and Future Directions

  2018cited by this paper
• Lymphoproliferative Disease in the Rectum 4 Years After Local Mesenchymal Stromal Cell Therapy for Refractory Perianal Crohn's Fistulas: A Case Report.

  2018cited by this paper
• Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial.

  2016cited by this paper
• Disappointing Durable Remission Rates in Complex Crohn's Disease Fistula

  2014cited by this paper
• Long-term outcome of perianal fistulizing Crohn's disease treated with infliximab.

  2013cited by this paper
• Opportunistic Infections With Anti-Tumor Necrosis Factor-α Therapy in Inflammatory Bowel Disease: Meta-Analysis of Randomized Controlled Trials

  2013cited by this paper
• Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn’s disease: results from a multicenter phase I/IIa clinical trial

  2013cited by this paper
• Autologous Expanded Adipose-Derived Stem Cells for the Treatment of Complex Cryptoglandular Perianal Fistulas: A Phase III Randomized Clinical Trial (FATT 1 Fistula Advanced Therapy Trial 1) and Long-term Evaluation

  2012cited by this paper
• Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease

  2011cited by this paper
• Mesenchymal stem cells as an immunomodulatory therapeutic strategy for autoimmune diseases.

  2011cited by this paper
• Mesenchymal Stem Cell Homing Capacity

  2009cited by this paper
• Pluripotency of mesenchymal stem cells derived from adult marrow

  2007cited by this paper
• An assessment of the incidence of fistula-in-ano in four countries of the European Union

  2007cited by this paper
• No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients

  2007cited by this paper
• Immunomodulatory properties of mesenchymal stromal cells.

  2007cited by this paper
• Practice Parameters for the Treatment of Perianal Abscess and Fistula-in-Ano  (Revised)

  2005cited by this paper
• Pluripotency of mesenchymal stem cells derived from adult marrow

  2002cited by this paper

• Application of platelet-rich plasma in treating refractory wounds following hemorrhoid surgery: a case report.

  2025cites this paper
• Long-term Outcomes of Primary Fistula Closure with Platelet-Rich Plasma: A Prospective Study.

  2025cites this paper
• Efficacy of Platelet-Rich Plasma in the Treatment of Anal Fistula – A Prospective Study

  2025cites this paper
• Mucosal advancement flap versus ligation of the inter-sphincteric fistula tract for management of trans-sphincteric perianal fistulas in the elderly: a retrospective study

  2025cites this paper
• Reply to “Innovative Endoscopic Approach for Staple Line Leaks Following Sleeve Gastrectomy: Promising Outcomes with Considerable Concerns”

  2024cites this paper
• Endoscopic Administration of Combined Autologous Mesenchymal Stem Cells and Platelet-Rich Plasma for the Treatment of Gastric Staple Line Leaks After Sleeve Gastrectomy

  2023cites this paper
• Mesenchymal Stem Cells and PRP combined therapy promotes gastric leak closure following sleeve gastrectomy

  2022cites this paper
• Mesenchymal Stem Cells and PRP Therapy Favorize Leak Closure After Sleeve Gastrectomy in Zucker Rats

  2022cites this paper
• Impact du nombre de chirurgies antérieures sur la continence anale et la cicatrisation des fistules anales récidivantes

  2021cites this paper
• Cryptoglandular Abscess and Fistula

  2021cites this paper
• ASSESSMENT OF RECURRENT ANAL FISTULAS TREATMENT WITH PLATELET-RICH PLASMA.

  2021cites this paper
• Impact of number of previous surgeries on the continence state and healing after repeat surgery for recurrent anal fistula.

  2021cites this paper
• Gastrobronchial Fistula: A Rare Complication of Postlaparascopic Sleeve Gastrectomy—A Case Report and Literature Review

  2021cites this paper
• Immunomodulatory effect of mesenchymal stem cells: Cell origin and cell quality variations

  2019cites this paper
• Stem Cell and Therapy Mesenchymal Stem Cells and PRP combined therapy promotes gastric leak closure following sleeve gastrectomy

  year unknowncites this paper